News Archives - Page 2 of 9

New publication: A series of anticancer natural products, isolated from leafy liverworts (bryophytes).

(more…)

By Christian Bailly, 1 year31 March 2023 ago

New publication: Binding of camptothecin anticancer drugs to ribosomal proteins L11 and L15

(more…)

By Christian Bailly, 1 year27 February 2023 ago

New publication: The soluble form of the TIM-3 immune checkpoint as a biomarker of disease progression and therapeutic response.

(more…)

By Christian Bailly, 1 year5 February 2023 ago

New publication: Identification of an inhibitor of the PD-1/PD-L1 checkpoint in oncology.

(more…)

By Christian Bailly, 1 year22 January 2023 ago

New publication: A series of anticancer natural products identified as α-tubulin binders.

(more…)

By Christian Bailly, 1 year22 January 2023 ago

CDMO activity: Head of Development & Manufacturing for Polygon Therapeutics (Sept 2022)

Development & Manufacturing of POLYGON therapeutic leader product PLG-101, a monoclonal antibody for the treatment of cardiovascular diseases (myocardial infacrtion). The antibody PLG-101 aims to enhance post-ischemic cardiac remodeling. Christian Bailly (Oncowitan) brings his exertise to guide the manufacturing of the producing cell line and GMP-made antibody, for subsequent clinical Read more…

By Christian Bailly, 1 year31 December 2022 ago